日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer.

获得性 CYP19A1 扩增是 ERα 转移性乳腺癌中芳香化酶抑制剂耐药性的早期特异性机制

Magnani Luca, Frige Gianmaria, Gadaleta Raffaella Maria, Corleone Giacomo, Fabris Sonia, Kempe Mannus H, Verschure Pernette J, Barozzi Iros, Vircillo Valentina, Hong Sung-Pil, Perone Ylenia, Saini Massimo, Trumpp Andreas, Viale Giuseppe, Neri Antonino, Ali Simak, Colleoni Marco Angelo, Pruneri Giancarlo, Minucci Saverio

The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features

唾液酸糖脂阶段特异性胚胎抗原4标记着具有间质特征的化疗耐药乳腺癌细胞亚群。

Aloia, Andrea; Petrova, Evgeniya; Tomiuk, Stefan; Bissels, Ute; Déas, Olivier; Saini, Massimo; Zickgraf, Franziska Maria; Wagner, Steve; Spaich, Saskia; Sütterlin, Marc; Schneeweiss, Andreas; Reitberger, Manuel; Rüberg, Silvia; Gerstmayer, Bernhard; Agorku, David; Knöbel, Sebastian; Terranegra, Annalisa; Falleni, Monica; Soldati, Laura; Sprick, Martin Ronald; Trumpp, Andreas; Judde, Jean-Gabriel; Bosio, Andreas; Cairo, Stefano; Hardt, Olaf